ML20211L662
| ML20211L662 | |
| Person / Time | |
|---|---|
| Issue date: | 09/29/1997 |
| From: | Randall K NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS) |
| To: | Stratton P AFFILIATION NOT ASSIGNED |
| References | |
| SSD, NUDOCS 9710100282 | |
| Download: ML20211L662 (1) | |
Text
.
I l
September 29,1997 Peter K. Stratton, M.D.
Ford Tel Medical Center 23800 Ford Road
Dearbom Heights,
MI 48127
Dear Dr. Stratton:
This letter verifies the receipt of your NRC Form 483 dated July 9,1997. We have made the appropriate name and address changes to our files. This form is a condition of the general license under 10 CFR 31.11 authorizing in vitro testing with byproduct material under general license.
When making changes to any of the information on the form, please reference your registration number 8954 and address the correspondence to Director, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington DC 20555.
If you have any questions or need further assistance, please contact me at (301) 415 8140.
Sincerely,
)5l KimBerly Randall, Registration Specialist
- Sealed Source Safety Section Medical, Academic, and Commercial Use Safety Branch Division of Industrial and Medical Nuclear Safety Office of Nuclear Material Safety and Safeguards Qistribution:
lD SBaggett SSSS r/f NE034 DOCUMENT NAME: p: 483.5947 Ta recahre a copy of this document. Indicate in the boa:
'C' - Copy without ettechment! enclosure
'E' - Copy with attachment / enclosure T = No copy OFFICE IMAB,gf,
l
[
l NAME KRandell DATE 9/P//97 9710100282 970929 l{l\\[l l!\\{l$lf}!!
l}ll!!!!!!!!!!{
PDR RC
- i-PDR